FDA Class I Recall Alert: Cordis INFINITI Angiographic Catheter
Recalled Product Information: Product Names: Cordis INFINITI Angiographic Catheter Product Codes: DQO Lot Number: 18223410 Distribution Dates: August 21, 2023, to... Read more.
PrecisePK Pioneers Model-Informed Precision Dosing and Pharmacokinetics Advancements in Argentina with Maza University
In a groundbreaking announcement today, PrecisePK solidifies an unprecedented partnership with Maza University, a monumental step in the realm of Argentina’s... Read more.
Amplity Health Unveils AI-Driven Survey Platform, Revolutionizing Early Drug Launch Insights
In a groundbreaking move, Contract Medical and Commercial Organization, Amplity Health, has introduced a pioneering AI-driven solution named Survey by AskX. This... Read more.
Supreme Court Considers Purdue Pharma Case, Balancing Legal Protections and Due Process
In a pivotal legal battle, the U.S. Supreme Court grapples with the Purdue Pharma case, navigating a delicate balance between righting a perceived legal misstep... Read more.
Merck KGaA Faces Significant Setback as Multiple Sclerosis Drug Falters in Advanced Trials
Merck KGaA’s (MRCG.DE) growth ambitions have taken a significant hit as its experimental multiple sclerosis (MS) drug, evobrutinib, fell short of its primary... Read more.
Home Remedies and Ointments for Treating Female Genital Pimples
Pimples on the private parts can be an uncomfortable and sometimes embarrassing issue that many females may face. While it’s essential to approach such matters... Read more.
Leal Health Leverages Generative AI to Optimize Cancer Treatment Matching for Patients
Leal Health, formerly known as Trialjectory, has unveiled a groundbreaking addition to its patient-centric, AI-powered treatment platform for cancer care. The company... Read more.
Global Acute Myeloid Leukemia (AML) Therapeutics Market Projected to Reach $1.6 Billion by 2030
The “Acute Myeloid Leukemia (AML) Therapeutics – Global Strategic Business Report” by ResearchAndMarkets.com reveals a robust growth projection... Read more.
ASOP Survey Reveals More Americans Buy Meds Online Despite Safety Risks
A recent survey commissioned by the Alliance for Safe Online Pharmacies (ASOP) Global Foundation highlights a significant increase in Americans buying prescription... Read more.
Qilu Pharmaceutical Announces Results from Phase II Study for iparomlimab for Advanced Solid Tumors at ESMO Asia, with an ORR of 45.8%
Qilu Pharmaceutical presented the latest results of the single-arm, phase II pivotal clinical study for iparomlimab (QL1604), an innovative Class 1 antibody monotherapy... Read more.